Article citationsMore>>

Zhang, H., Zhang, J., Wang, Z., Lu, D., Feng, J., Yang, D., Chen, X. and Yan, X. (2013) CD146 Is a Potential Marker for the Diagnosis of Malignancy in Cervical and Endometrial Cancer. Oncology Letters, 5, 1189-1194.
https://dx.doi.org/10.3892/ol.2013.1147

has been cited by the following article:

• TITLE: The Application of Quantum Dots Double-Labeling Immunofluorescence Technology in Detection of PR and CD146 in Paraffin-Embedded Tissue Sections of Endometrioid Adenocarcinoma

  AUTHORS: Jianping Zheng, Qing Huang, Lei Zhang, Yong Chen, Jinpeng Jiang, Cunjian Yi

  KEYWORDS: Endometrioid Adenocarcinoma, PR, CD146, QDs Double-Labeling Immunofluorescence

  JOURNAL NAME: Yangtze Medicine, Vol.1 No.1, March 30, 2017

  ABSTRACT: Objective: The aim was to detect the expression of PR and CD146 in paraf-fin-embedded tissue sections of endometrioid adenocarcinoma by using QDs double-labeling immunofluorescence, and evaluate the applied value of QDs double-labeling immunofluorescence in endometrioid adenocarcinoma. Methods: To detect the expression of PR and CD146 on 140 cases of paraffin-embedded tissue sections of endometrioid adenocarcinoma by using QDS double-labeling immunofluorescence. Results: The co-expression of PR and CD146 in the endometrioid adenocarcinoma can be detected by QDs double-labeling immunofluorescence, and there was no correlation between them (P > 0.05). Conclusion: QDs double-labeling immunofluorescence can detect the localization and co-expression of PR and CD146 in the endometrioid adenocarcinoma.